Resolution 2021-55 - Laserfiche WebLink

Home Browse Search

DocuSign Envelope ID: 7636E61D-37CF-4104-8D18-3BD87A8BD23D improvements permitted under Louisville Municipal Code section 3.24.060 (as enacted by Ordinance No. 1507, Series 2007), which includes, but is not limited to, creation of new tax revenue and new basic jobs. The Building Permit Fee and Construction Use Tax rebates provided for under this Agreement are solely for construction activities and purchases for the Project during the periods stated in Sections 1-2, above. Any previous or subsequent purchases and construction activities shall be subject to payment without rebate of all applicable Building Permit Fees and Construction Use Taxes. 7. Effect of Change in Tax Rate. Any increase or decrease in the City General Sales, Construction Use, or Use Tax- Tangible Goods rate above or below the applicable tax rate on the date of execution of this Agreement shall not affect the rebate payments to be made pursuant to this Agreement; rather, the amount of the rebate payments will continue to be based upon the General Sales, Construction Use, or Use Tax- Tangible Goods rates applicable on the date of execution of this Agreement (excluding the City's 0.375% Open Space Tax, 0.125% Historic Preservation Tax, and 0.150% Recreation Center Tax). Any decrease in the City General Sales, Construction Use, or Use Tax- Tangible Goods rates shall cause the amount of the rebate payments made pursuant to this Agreement to be based on the applicable percentage of revenues actually received by the City from application of the tax rate affected (excluding said Open Space, Historic Preservation, Recreation Center, or future special Sales or Use taxes). 8. Entire Agreement; Notices. This instrument shall constitute the entire agreement between the City and the Company and supersedes any prior agreements between the parties and their agents or representatives, all of which are merged into and revoked by this Agreement with respect to its subject matter. Contact information is as follows: If to Company: Umoja Biopharma Inc. Attn: Andrew Scharenberg, CEO 1920 Terry Avenue Seattle, WA 98101 206-963-8643 tonya.swick@umoja-biopharma.com If to City: Louisville City Hall Attn: Economic Vitality 749 Main Street Louisville, CO 80027 303.335.4531 mpierce@louisvilleco.gov Page 3 of 6